FXN and proteostasis deficiencies: The evidence that the pathogenic mechanism in FRDA mutant frataxin results from frataxin misfolding and instability suggests that, although quite different from other neurodegenerative diseases involving toxic aggregation and metal ions [49], FRDA in compound heterozygous patients can be classified as a protein misfolding disease [50].